As the world deals with a pandemic, there remains another global challenge that cannot be ignored. Use of broad-spectrum antibiotics may be justified as we are trying to treat a novel disease condition, which in turn could lead to an increase in antimicrobial resistance. We can decrease morbidity, mortality, and health care costs by controlling antimicrobial resistance, but it requires antimicrobial stewardship. Major components of effective and timely antimicrobial stewardship are diagnostic stewardship, infection prevention and control, and integration of COVID-19 specific flags into electronic health records, all of which may be integrated into current strategies of COVID-19 mitigation and management. Going through the influenza season of 2020, implementation of antimicrobial stewardship education efforts in the United States can help us contend with influenza in addition to COVID-19 and any bacterial co-infections or secondary infections. Additional solutions include the development of vaccines, alternative therapies such as antibodies, and advanced diagnostics using advances in genomics and computer science.

中文翻译：

---

在COVID-19中，抗菌素管理的关键作用。

在世界应对大流行的同时，仍然存在着另一个不可忽视的全球挑战。当我们尝试治疗一种新型疾病时，使用广谱抗生素可能是合理的，这反过来又可能导致抗菌素耐药性的增加。我们可以通过控制抗菌素耐药性来降低发病率，死亡率和医疗保健成本，但这需要抗菌素的管理。有效和及时的抗菌管理的主要组成部分是诊断管理，感染的预防和控制，以及将COVID-19特定标志集成到电子健康记录中，所有这些都可以集成到当前的COVID-19缓解和管理策略中。经历了2020年的流感季节，在美国实施抗菌药物管理教育工作，除了可以预防COVID-19以及任何细菌共感染或继发感染外，还可以帮助我们应对流感。其他解决方案包括开发疫苗，替代疗法（例如抗体）以及利用基因组学和计算机科学的进步进行的高级诊断。